Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo

Clinical Science

Volumn 98, Issue 3, 2000, Pages 277-282

  Chu, Z M ^a   Croft, K D ^a   Kingsbury, D A ^a   Falck, J R ^b   Reddy, K M ^b   Beilin, L J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cytochrome P450; Spontaneously hypertensive rat; Vasoconstriction

Indexed keywords

ANGIOTENSIN; ARACHIDONIC ACID; CARBON 14; CYTOCHROME P450; ENZYME INHIBITOR; HYDROXYICOSATETRAENOIC ACID; MESYLIC ACID DERIVATIVE; METHYLSULPHONYL 12,12 DIBROMODODEC 11 ENAMIDE; MICONAZOLE; NORADRENALIN; OXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG HYDROXYLATION; ELECTROSTIMULATION; EPOXIDATION; FEMALE; IN VITRO STUDY; ISOTOPE LABELING; MESENTERIC VEIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE; VASOCONSTRICTION;

EID: 0034060115     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0980277     Document Type: Article

References (20)

1. 1 Capdevila, J. H., Falck, J. R. and Estabrook, R. W. (1992) Cytochrome P450 and the arachidonate cascade. FASEB J. 6, 731-736
2. 2 Miller, M. J. S., Quilley, J. and McGiff, J. C. (1986) Ecosanoid-dependent mechanisms of the regulation of blood pressure. Handb. Hypertens. 8, 518-602
3. 3 Imig, J. D., Zou, A. P., Stec, D. E., Harder, D. R., Falck, J. R. and Roman, J. R. (1996) Formation and action of 20-HETE on rat renal arterioles. Am. J. Physiol. 270, R217-R227
4. 4 McGiff, J. C., Steinberg, M. and Quilley, J. (1996) Missing links: cytochrome P450 arachidonate products, a new class of lipid mediators. Trends Cardiovasc. Med. 6, 4-10
5. 5 Campbell, W. B., Gebremedhin, D., Pratt, P. F. and Harder, D. R. (1996) Identification of epoxyeicosatrienoic acids as endothelium derived hyperpolarizing factors. Circ. Res. 78, 415-423
6. 6 Harder, D. R., Campbell, W. B. and Roman, R. J. (1995) Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32, 79-92
7. 7 Ma, Y. H., Imig, J. D., Harder, D. R. and Roman, R. J. (1993) Role of cytochrome P450 in elevating renal vascular tone in spontaneously hypertensive rats. J. Vasc. Res. 30, 53-60
8. 8 Kroetz, D. L., Huse, L. M., Thuresson, A. and Grillo, M. P. (1997) Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol. Pharmacol. 52, 362-372
9. 9 Ping, S. U., Kaushal, K. M. and Kroetz, D. L. (1998) Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR. Am. J. Physiol. 275, R426-R438
10. 10 Carroll, M. A., Balazy, M., Margiotta, P., Huang, D. D., Falck, J. R. and McGiff, J. C. (1996) Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol. 271, R863-R869
11. 11 Capdevila, J., Gil, L., Orellana, M. et al. (1988) Inhibitors of cytochrome P450 dependent arachidonic acid metabolism. Arch. Biochem. Biophys. 261, 257-263
12. 12 Wang, M. H., Brand-Schieber, E., Zand, B. A. et al. (1998) Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J. Pharmacol. Exp. Ther. 284, 966-973
13. 13 Capdevila, J. H., Falck, J. R., Dishman, E. and Karara, A. (1990) Cytochrome P-450 arachidonate oxygenase. Methods Enzymol. 187, 385-394
14. 14 Chu, Z. M. and Beilin, L. J. (1993) Mechanism of vasodilation: studies of the roles of prostaglandins and nitric-oxide in vascular reactivity in the in-situ blood perfused mesenteric resistance vessels of pregnant rats. Br. J. Pharmacol. 109, 322-329
15. 15 Alonso-Galicia, M., Drummond, H. A., Reddy, K. K., Falck, J. R. and Roman, R. J. (1997) Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 29, 320-325
16. 16 Brand-Schieber, E., Takizawa, H., Falck, J. R., Laniado-Schwartzman, M. and Nasjletti, A. (1996) Increased dietary salt attenuates a renal vasoconstrictor mechanism mediated by 20-HETE. Hypertension 28, 542 (abstract)
17. 17 Carroll, M. A., Croft, K. D. and McGiff, J. C. (1997) Angiotensin II stimulated release of cytochrome P-450 derived hydroxyeicosatetraenoic acids (HETEs) from renal microvessels. Microcirculation 4, 189 (abstract)
18. 18 Lange, A., Gebremedhin, D., Narayanan, J. and Harder, D. (1997) 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J. Biol. Chem. 272, 27345-27352
19. 19 Saito, F., Hori, M. T., Ideguchi, Y. et al. (1992) 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle. Hypertension 20, 138-143
20. 20 Stern, N., Golub, M., Nozawa, K. et al. (1989) Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am. J. Physiol. 257, H434-H443